The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
BriaCell Therapeutics Corp(NASDAQ:BCTX)


BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The ...
Website: http://www.briacell.com
Founded: 2006
CEO: Bill Williams
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
BriaCell Therapeutics Corp Days Payable Outstanding ttm (DPO)
BriaCell Therapeutics Corp Days Inventory Outstanding ttm (DIO)
BriaCell Therapeutics Corp Op Cashflow Per Share ttm
BriaCell Therapeutics Corp Free Cashflow Per Share ttm
BriaCell Therapeutics Corp Cash Per Share ttm
BriaCell Therapeutics Corp (GAAP) P/E ratio ttm
BriaCell Therapeutics Corp P/B ratio ttm
No extra charts and metrics for this ticker.